Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 31% ± 22% | |
glutamatergic neuron | 3 studies | 42% ± 23% |
Insufficient scRNA-seq data for expression of SPDYA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 99% | 44.52 | 1432 / 1445 | 53% | 0.92 | 97 / 183 |
uterus | 100% | 71.35 | 170 / 170 | 27% | 0.54 | 123 / 459 |
ovary | 100% | 95.47 | 180 / 180 | 24% | 0.36 | 103 / 430 |
lung | 100% | 52.23 | 577 / 578 | 16% | 0.38 | 188 / 1155 |
prostate | 100% | 55.64 | 245 / 245 | 8% | 0.27 | 41 / 502 |
bladder | 100% | 35.33 | 21 / 21 | 7% | 0.28 | 35 / 504 |
brain | 97% | 38.30 | 2571 / 2642 | 8% | 0.13 | 59 / 705 |
breast | 98% | 48.15 | 452 / 459 | 5% | 0.16 | 53 / 1118 |
stomach | 97% | 29.00 | 347 / 359 | 6% | 0.16 | 18 / 286 |
kidney | 96% | 34.80 | 85 / 89 | 6% | 0.12 | 57 / 901 |
thymus | 100% | 51.68 | 653 / 653 | 2% | 0.02 | 11 / 605 |
intestine | 98% | 33.74 | 948 / 966 | 3% | 0.09 | 17 / 527 |
skin | 98% | 43.65 | 1777 / 1809 | 2% | 0.02 | 9 / 472 |
spleen | 100% | 53.58 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 77.58 | 1323 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 41.77 | 1192 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 98% | 34.82 | 252 / 258 | 0% | 0 | 0 / 230 |
pancreas | 89% | 20.40 | 291 / 328 | 3% | 0.06 | 5 / 178 |
liver | 90% | 20.30 | 204 / 226 | 1% | 0.01 | 4 / 406 |
heart | 84% | 27.38 | 727 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 26.31 | 761 / 929 | 0% | 0 | 0 / 0 |
muscle | 64% | 12.81 | 511 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 24% | 0.35 | 11 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0070197 | Biological process | meiotic attachment of telomere to nuclear envelope |
GO_0007283 | Biological process | spermatogenesis |
GO_0006974 | Biological process | DNA damage response |
GO_0045737 | Biological process | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0016233 | Biological process | telomere capping |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0070200 | Biological process | establishment of protein localization to telomere |
GO_0048477 | Biological process | oogenesis |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0000082 | Biological process | G1/S transition of mitotic cell cycle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005635 | Cellular component | nuclear envelope |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0001741 | Cellular component | XY body |
GO_0005634 | Cellular component | nucleus |
GO_0019901 | Molecular function | protein kinase binding |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SPDYA |
Protein name | Speedy/RINGO cell cycle regulator family member A Speedy protein A (Rapid inducer of G2/M progression in oocytes A) (RINGO A) (hSpy/Ringo A) (Speedy-1) (Spy1) |
Synonyms | SPDY1 SPY1 |
Description | FUNCTION: Regulates the G1/S phase transition of the cell cycle by binding and activating CDK1 and CDK2 . Contributes to CDK2 activation without promoting CDK2 phosphorylation, by inducing a conformation change of the CDK2 T-loop that obstructs the substrate-binding cleft prior to kinase activation . Mediates cell survival during the DNA damage process through activation of CDK2 . . |
Accessions | ENST00000449210.1 E7EPV1 Q5MJ70 ENST00000334056.10 [Q5MJ70-2] ENST00000439646.1 ENST00000379579.8 [Q5MJ70-2] H7C0J1 |